AN
Ankit Natwarlal Patel
About Ankit Natwarlal Patel
Data last updated:
Ankit Natwarlal Patel is a Director at Epigral Limited (since 2016), Managing Director at Meghmani Organics Limited (since 2023) and Designated Partner at Meghmani Dyes And Intermediates Llp (since 2016), and holds 13 more current directorships. The companies operate in Chemicals and Materials, Agriculture and Manufacturing. The 10 current companies with reported revenue have a combined latest revenue of ₹6,254 Cr; the largest is Epigral Limited at ₹2,565 Cr (FY 2025). Earlier, Ankit Natwarlal Patel was a Director at Meghmani Chemtech Limited (2008–2011) and Director at Vidhi Global Chemicals Limited (from 2008) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 May 2016 | 2007 | ₹2,565 Cr (FY 2025) | Active | |
| Managing Director | 14 Aug 2023 | 2019 | ₹2,124 Cr (FY 2025) | Active | |
| Designated Partner | 18 Mar 2016 | 2016 | ₹728 Cr (FY 2022) | Active | |
| Designated Partner | 09 Jun 2022 | 2014 | ₹442 Cr (FY 2025) | Active | |
| Partner | 23 Sep 2011 | 2011 | ₹225 Cr (FY 2023) | Active | |
| Director | 04 Nov 2019 | 2019 | ₹110 Cr (FY 2025) | Active | |
| Whole-Time Director | 06 Jun 2023 | 2021 | ₹40.55 Cr (FY 2025) | Active | |
| Director | 08 Nov 2021 | 2021 | ₹18.06 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Jul 2008 | 2008 | Strike Off | ||
| Director | 31 Jul 2008 | 2008 | ₹3 Lakh (FY 2021) | Strike Off | |
| Director | 23 Jan 2012 | 2012 | Converted To Llp | ||
| Ceo | 22 May 2017 | 1995 | ₹2,124 Cr (FY 2025) | Amalgamated | |
| Director | 27 Jan 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ankit Natwarlal Patel
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankit Natwarlal Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankit Natwarlal Patel
Ankit Natwarlal Patel currently holds 16 directorships: Epigral Limited (Director, since 10 May 2016, revenue ₹2,565 Cr (FY 2025)); Meghmani Organics Limited (Managing Director, since 14 Aug 2023, revenue ₹2,124 Cr (FY 2025)); Meghmani Dyes And Intermediates Llp (Designated Partner, since 18 Mar 2016, revenue ₹728 Cr (FY 2022)); Matangi Industries Limited Liability Partnership (Designated Partner, since 09 Jun 2022, revenue ₹442 Cr (FY 2025)); Navratan Specialty Chemicals Llp (Partner, since 23 Sep 2011, revenue ₹225 Cr (FY 2023)); and 11 more.
Ankit Natwarlal Patel was first appointed on 23 Jul 2008 as Director at Meghmani Chemtech Limited. The most recent appointment on record is 01 Apr 2024 at Navratan Galaxy Llp.
The 10 current companies of Ankit Natwarlal Patel that report revenue have a combined latest revenue of ₹6,254 Cr: Epigral Limited ₹2,565 Cr (FY 2025); Meghmani Organics Limited ₹2,124 Cr (FY 2025); Meghmani Dyes And Intermediates Llp ₹728 Cr (FY 2022); Matangi Industries Limited Liability Partnership ₹442 Cr (FY 2025); Navratan Specialty Chemicals Llp ₹225 Cr (FY 2023); and 5 more.
Ankit Natwarlal Patel held 5 earlier board appointments: Meghmani Chemtech Limited (Director, 23 Jul 2008 to 18 Mar 2011); Vidhi Global Chemicals Limited (Director, from 31 Jul 2008); Uniworth Enterprises Private Limited (Director, from 23 Jan 2012); Meghmani Organics Limited (Ceo, from 22 May 2017); Meghmani Advanced Sciences Limited (Director, from 27 Jan 2021).
The current boards of Ankit Natwarlal Patel's companies include Darshan Anandbhai Patel (Epigral Limited), Gaurang Ghanshyam Trivedi (Epigral Limited), Gaurang Ghanshyam Trivedi (Epigral Limited), Kamlesh Mehta (Epigral Limited), Kanubhai Shakarabhai Patel (Epigral Limited), Karana Rameshbhai Patel (Epigral Limited), among others.